Two Regimens Active in BRCA+ Triple-Negative Breast Cancer

]]>(MedPage Today) -- Neoadjuvant treatment with either of two chemotherapy regimens led to high rates of pathologic complete response (pCR) in early-stage, BRCA-mutated triple-negative breast cancer (TNBC), a large retrospective review showed.Three...